journal article·2014-03-25Open access

Efficient Intracellular Delivery of Molecules with High Cell Viability Using Nanosecond-Pulsed Laser-Activated Carbon Nanoparticles

Aritra Sengupta, Sean C. Kelly, Nishant Dwivedi, Naresh Thadhani, Mark R. Prausnitz

ACS Nano· Volume 8· Issue 3

Abstract

Conventional physical and chemical methods that efficiently deliver molecules into cells are often associated with low cell viability. In this study, we evaluated the cellular effects of carbon nanoparticles believed to emit photoacoustic waves due to nanosecond-pulse laser activation to test the hypothesis that this method could achieve efficient intracellular delivery while maintaining high cell viability. Suspensions of DU145 human prostate carcinoma cells, carbon black (CB) nanoparticles, and calcein were exposed to 5-9 ns long laser pulses of near-infrared (1064 nm wavelength) light and then analyzed by flow cytometry for intracellular uptake of calcein and cell viability by propidium iodide staining. We found that intracellular uptake increased and in some cases saturated at high levels with only small losses in cell viability as a result of increasing laser fluence, laser exposure time, and as a unifying parameter, the total laser energy. Changing interpulse spacing between 0.1 and 10 s intervals showed no significant change in bioeffects, suggesting that the effects of each pulse were independent when spaced by at least 0.1 s intervals. Pretreatment of CB nanoparticles to intense laser exposure followed by mixing with cells also had no significant effect on uptake or viability. Similar uptake and viability were seen when CB nanoparticles were substituted with India ink, when DU145 cells were substituted with H9c2 rat cardiomyoblast cells, and when calcein was substituted with FITC-dextran. The best laser exposure conditions tested led to 88% of cells with intracellular uptake and close to 100% viability, indicating that nanosecond-pulse laser-activated carbon nanoparticles can achieve efficient intracellular delivery while maintaining high cell viability.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Laser-Ablation Synthesis of Nanoparticles · Ultrasound and Cavitation Phenomena · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States

School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States

School of Medicine, Boston University, Boston, Massachusetts 02118, United States

References (38)

Show source-provided references
1. Torchilin V. P. · Annu. Rev. Biomed. Eng. · 2006 · 8 · 34310.1146/annurev.bioeng.8.061505.095735 ↗
2. Templeton N. S. · 200810.1201/9780849387999 ↗
3. Yang A. · Curr. Opin. Cell Biol. · 2010 · 22 · 83710.1016/j.ceb.2010.08.001 ↗
4. Perez-Pinzon M. A. · J. Cereb. Blood Flow Metab. · 2012 · 32 · 136210.1038/jcbfm.2012.32 ↗
5. Sioud M. · 2009 · 48710.1007/978-1-60327-547-7 ↗
6. Lodhish H. · 2000
7. Panyam J. · Adv. Drug Delivery Rev. · 2012 · 64 · 6110.1016/j.addr.2012.09.023 ↗
8. Varkouhi A. K. · J. Controlled Release · 2011 · 151 · 22010.1016/j.jconrel.2010.11.004 ↗
9. Thomas C. E. · Nat. Rev. Genet. · 2003 · 4 · 34610.1038/nrg1066 ↗
10. Meacham J. M. · J. Lab. Autom. · 2013 · 1
11. Gehl J. · Acta Physiol. Scand. · 2003 · 177 · 43710.1046/j.1365-201X.2003.01093.x ↗
12. Liu Y. · Ultrasound Med. Biol. · 2012 · 38 · 87610.1016/j.ultrasmedbio.2012.01.006 ↗
13. 10.1016/j.addr.2013.11.00810.1016/j.addr.2013.11.008 ↗
14. Zhang Y. · Curr. Opin. Biotechnol. · 2008 · 19 · 50610.1016/j.copbio.2008.07.005 ↗
15. Zhong P. · J. Acoust. Soc. Am. · 1999 · 105 · 199710.1121/1.426733 ↗
16. Kodama T. · Biochim. Biophys. Acta, Mol. Cell Res. · 2002 · 1542 · 18610.1016/S0167-4889(01)00177-X ↗
17. Yao C. · J. Biomed. Opt. · 2009 · 14 · 05403410.1117/1.3253320 ↗
18. Qin Z. · Chem. Soc. Rev. · 2012 · 41 · 119110.1039/C1CS15184C ↗
19. Pitsillides C. M. · Biophys. J. · 2003 · 84 · 402310.1016/S0006-3495(03)75128-5 ↗
20. Vivero-Escoto J. L. · J. Am. Chem. Soc. · 2009 · 131 · 346210.1021/ja900025f ↗
21. Paasonen L. · J. Controlled Release · 2010 · 147 · 13610.1016/j.jconrel.2010.07.095 ↗
22. Angelos S. · J. Phys. Chem. C · 2007 · 111 · 658910.1021/jp070721l ↗
23. Han G. · Angew. Chem., Int. Ed. · 2006 · 45 · 316510.1002/anie.200600214 ↗
24. El-Sayed I. H. · Cancer Lett. · 2006 · 239 · 12910.1016/j.canlet.2005.07.035 ↗
25. Chen H. X. · Science (Washington, DC, U.S.) · 1995 · 270 · 96310.1126/science.270.5238.963 ↗
26. Chakravarty P. · Nat. Nanotechnol. · 2010 · 5 · 60710.1038/nnano.2010.126 ↗
27. Halpern B. · Br. J. Exp. Pathol. · 1953 · 34 · 426
28. Madsen S. J. · Phys. Med. Biol. · 1992 · 37 · 98510.1088/0031-9155/37/4/012 ↗
29. Faraggi E. · J. Biomed. Opt. · 2005 · 10 · 06402910.1117/1.2139970 ↗
30. Leighton T. G. · 1994
31. Prausnitz M. R. · Biophys. J. · 1993 · 65 · 41410.1016/S0006-3495(93)81081-6 ↗
32. Oliver J. D. · J. Am. Soc. Nephrol. · 1992 · 3 · 21410.1681/ASN.V32214 ↗
33. Escoffre J. M. · Curr. Pharm. Des. · 2012 · 18 · 340610.2174/138161212801227087 ↗
34. Malietzis G. · Br. J. Radiol. · 2013 · 86 · 2013004410.1259/bjr.20130044 ↗
35. Stone K. R. · Int. J. Cancer · 1978 · 21 · 27410.1002/ijc.2910210305 ↗
36. Guzman H. R. · J. Acoust. Soc. Am. · 2001 · 110 · 58810.1121/1.1376131 ↗
37. Schlicher R. K. · Ultrasound Med. Biol. · 2006 · 32 · 91510.1016/j.ultrasmedbio.2006.02.1416 ↗
38. Watkins S. · In Vitro Cell. Dev. Biol.: Anim. · 2011 · 47 · 12510.1007/s11626-010-9368-1 ↗